Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries
|
October 2017
Building upon the IMPT's report: "Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development," the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in development: daily oral tablets; on-demand, intermediate acting (e.g., gel, film, vaginal insert, barrier method); long-acting topical (e.g., patch, intravaginal ring [IVR]); and ultra-long-acting systemic (e.g., implant, injectable, intrauterine device [IUD]). This exercise aimed to synthesize learnings from end-user research in HIV prevention, family planning, and MPT development to inform target-setting around the ten identified STP attributes. Click here to View Report |
In this Technical Brief:
Health Risk(s): HIV Unintended Pregnancy
Product Type(s): ARVs Cervical Barrier Contraceptives Implants IUD IVR (Intravaginal Rings) MPTs Vaginal Cream/Gel Vaginal Film Other or N/A
Topic(s):Education MPTs Product Development Product Introduction / Uptake
Region(s): Global
